ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

roche registration gmbh - sakvinavir - okužbe z virusom hiv - antivirusi za sistemsko uporabo - zdravilo invirase je indicirano za zdravljenje odraslih bolnikov s hiv-1. zdravilo invirase se lahko daje le v kombinaciji z ritonavirjem in drugimi protiretrovirusnimi zdravili.

ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - immunologicals za skupin felidae, - mačke - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs. onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.

ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - immunologicals za skupin felidae, - mačke - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. nastopi imunosti so dokazali en teden po primarno cepljenje seveda za rhinotracheitis, calicivirus, chlamydophila felis in panleucopenia komponente. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

laboratorios syva, s.a.u. - inaktivirano bolezni modrikastega jezika virus, serotip 1, sev alg2006/01 e1, inaktivirano bolezni modrikastega jezika virus, serotip 4, sev btv-4/spa-1/2004, inaktivirano bolezni modrikastega jezika virus, serotip 8, sev bel2006/01 - inaktivirano virusna cepiva - cattle; sheep - za aktivno imunizacijo ovc za preprečevanje viraemia in zmanjšanje kliničnih znakov bolezni in poškodb, ki jih povzročajo bolezni modrikastega jezika virus serotypes 1 in/ali 8 in/ali za zmanjšanje viraemia* in klinični znaki in poškodb, ki jih povzročajo bolezni modrikastega jezika virus serotip 4for aktivno imunizacijo goveda za preprečevanje viraemia zaradi bolezni modrikastega jezika virus serotypes 1 in/ali 8 in/ali za zmanjšanje viraemia* zaradi bolezni modrikastega jezika virus serotip 4.

ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

dynavax gmbh - površinski antigen hepatitisa b - hepatitis b - cepiva - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.

ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

ceva santé animale - influenza a virus/human strain: a/jena/vi5258/2009 (h1n1)pdm09, inactivated - imunologi, inaktivirana virusna cepiva za prašiče, virus svinjske gripe - prašiči - aktivna imunizacija prašičev od starosti 8 tednov naprej proti virusu pandemičnega virusa hroščev virusa h1n1 za zmanjšanje virusne obremenitve pljuč in izločanja virusa. the vaccine can be used during pregnancy up to three weeks before expected farrowing and during lactation lactation.

ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

ceva santé animale - oslabljen živ virus cepiva proti steklini, sev spbn gasgas - immunologicals za canidae, Živo virusna cepiva - red foxes (vulpes vulpes); raccoon dogs (nyctereutes procyonoides) - za aktivno imunizacijo lisic in rakunskih psov proti steklini za preprečevanje okužb in smrtnosti.

ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

glaxosmithkline biologicals sa - recombinant varicella zoster virus glycoprotein e - herpes zoster - cepiva - shingrix is indicated for prevention of herpes zoster (hz) and post-herpetic neuralgia (phn), in:adults 50 years of age or older;adults 18 years of age or older at increased risk of hz. uporaba shingrix mora biti v skladu z uradnimi priporočili.

ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

elanco gmbh - puk-spdv-poly2#1 dna plazmida kodiranje za lososa trebušne slinavke bolezni virus beljakovin - immunologicals za atlantski losos, - atlantski losos - za aktivno imunizacijo atlantskega lososa za zmanjšanje oslabljena dnevne telesne mase in zmanjšanje umrljivosti in srca, trebušne slinavke in skeletne mišice poškodb, ki jih povzročajo trebušni slinavki, bolezni po okužbi z salmonidne alphavirus podtipa 3 (sav3).

স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sirup - vitamini kompleksa b brez dodatkov